EMAAR Group: Tbilisi Waterfront,Gonio Yachts, Marina projects have been developed in full compliance with local regulations, environmental priorities,sustainability standards
EMAAR Group on Monday said The Tbilisi Waterfront and Gonio Yachts and Marina projects had been developed under the guidance of national and municipal authorities, ensuring full compliance with local regulations, environmental priorities and sustainability standards.
The statement noted that both projects prioritised the preservation of the natural habitat and biodiversity.
“Eagle Hills’ involvement stems from a deep belief in the growth potential of Georgia, its dynamic tourism sector and the Government’s vision to create a progressive investment environment. Our projects – Tbilisi Waterfront and Gonio Yachts and Marina – represent long-term commitments to Georgia’s economic and social growth, with the aim of creating lasting value for local communities and future generations. Both projects have been developed under the guidance of national and municipal authorities, ensuring full compliance with local regulations, environmental priorities and sustainability standards”, EMAAR Group said.
“Eagle Hills places great importance on respecting the natural landscape and all research and design directions take into account the requirements set by relevant Government institutions and environmental experts at all stages. In Tbilisi and Batumi, this philosophy is embedded in energy-efficient infrastructure, green mobility networks and a deep commitment to environmental responsibility. Both projects prioritise the preservation of natural habitats, biodiversity and the protection of migratory bird reserves on the Black Sea coast through sustainable design, responsible land and coastal management, and the protection of pristine landscapes”, the statement continued.
EMAAR Group further added that they focus on implementing projects that create jobs, support local industries, improve tourism infrastructure, and attract international investment, which would directly contribute to Georgia's GDP growth and long-term prosperity.
“Eagle Hills, which operates in 12 countries, has a proven track record in creating world-class mixed-use complexes and hospitality destinations, including Belgrade Waterfront in Serbia and the United Arab Emirates, as well as projects in Latvia and Albania. We are proud to announce that the Eagle Hills Georgia presentation center was officially opened in Tbilisi on October 21, 2025, marking a significant milestone in the project’s launch. Additional details about both projects will be gradually released on our official channels and social media platforms in the coming period”, the statement concluded.
Other News
EBRD promotes domestic production of pharmaceuticals in Uzbekistan
08.01.2026.17:08
The European Bank for Reconstruction and Development (EBRD) is promoting further growth in domestic production of pharmaceutical products in Uzbekistan by supporting the operations of leading local manufacturer Nika Pharm.
Nika Pharm will use the EBRD loan of up to US$ 20 million to restructure its balance sheet and upgrade equipment and facilities in order to increase production capacity, improve product quality and bring the entire manufacturing process into compliance with the Good Manufacturing Practice (GMP) standards of the World Health Organisation’s certification scheme.
The company has been an EBRD client since 2021 and is a well-established producer of tablets, capsules, sachets and nasal sprays for use in the treatment of common colds, as well as in gastroenterology, paediatrics and urology. During this time, Nika Pharm has become a leader in several key segments, including decongestants, and has shown strong and sustainable growth by replacing imports with high-quality local production.
The project will help to expand Nika Pharm’s manufacturing base, improve its sustainability and efficiency, and lead to an average 140 per cent increase in the company’s production of generic pharmaceuticals and prescription drugs. Together with GMP certification, this will allow Nika Pharm to strengthen its position both domestically and regionally.
Uzbekistan’s rapidly growing pharmaceuticals market, which is set to expand by a further 10 per cent by 2029, is dominated (around 75 per cent) by imported medicines. The project will help contribute to the government’s plan of eventually bringing the share of locally produced pharmaceuticals to 80 per cent.
The EBRD has invested over US$ 6.6 billion in Uzbekistan to date through 196 projects, with the majority of those funds supporting private entrepreneurship, contributing to the country’s economic development.